Page 7 - Bioscience Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioscience segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioscience Segment Today - Breaking & Trending Today

Grifols (NASDAQ:GRFS) Rating Increased to Buy at StockNews.com

Grifols (NASDAQ:GRFS – Get Rating) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Wednesday. Other equities research analysts have also recently issued research reports about the company. Jefferies Financial Group raised Grifols from a “hold” rating to a “buy” rating in a research […] ....

Morgan Stanley , Norges Bank , Jefferies Financial Group , Grifols Company Profile , First Trust Advisors , Get Rating , Financial Group , Trust Advisors , World Investors , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs , Stocknews Com ,

Grifols, S.A. (NASDAQ:GRFS) Receives $13.53 Consensus Target Price from Analysts

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are presently covering the firm, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month […] ....

Morgan Stanley , Advisor Group Holdings Inc , Grifols Company Profile , Jefferies Financial Group , Quadrant Capital Group , Get Rating , Financial Advisors , Group Holdings , Capital Group , Creative Planning , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Stock Price Up 6.5%

Grifols, S.A. (NASDAQ:GRFS – Get Rating) rose 6.5% during trading on Thursday . The stock traded as high as $7.09 and last traded at $7.08. Approximately 219,014 shares were traded during trading, a decline of 78% from the average daily volume of 1,014,273 shares. The stock had previously closed at $6.65. Wall Street Analysts Forecast […] ....

Ronald Blue Trust Inc , Credit Suisse Group , Brinker Capital Investments , Jefferies Financial Group , Morgan Stanley , Quadrant Capital Group , Get Rating , Financial Group , Suisse Group , Financial Advisors , Blue Trust , Capital Group , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Shares Gap Up to $10.38

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) gapped up before the market opened on Friday . The stock had previously closed at $10.38, but opened at $10.73. Grifols shares last traded at $10.73, with a volume of 200 shares. Several research firms have commented on GRFS. Berenberg Bank decreased their price target on shares […] ....

Lindbrook Capital , Advisors Inc , Advisornet Financial Inc , Jpmorgan Chase Co , Berenberg Bank , Zacks Investment Research , Get Rating , Wealth Advisors , Net Financial Inc , Bio Supplies , Bioscience Segment , Hospital Segment , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Upgraded to "Hold" at Zacks Investment Research

Zacks Investment Research upgraded shares of Grifols (NASDAQ:GRFS – Get Rating) from a sell rating to a hold rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and […] ....

Comunidad Autonoma De Cataluna , Lindbrook Capital , Advisornet Financial Inc , Grifols Company Profile Get Rating , Berenberg Bank , Zacks Investment Research , Hospital Division , Jpmorgan Chase Co , Advisors Inc , Bioscience Division , Transfusion Centers , Get Rating , Diagnostic Division , Hospital Blood Banks , Wealth Advisors , Net Financial Inc , Company Profile , Bio Supplies , Bioscience Segment , Hospital Segment , Nasdaq Grfs ,